drugset / Trial / NCT00303420

Alteplase for Blood Flow Restoration in Hemodialysis Catheters

NCT00303420

Phase 4 Terminated 180 enrolled University of Manitoba Hoffmann-La Roche · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

We are investigating a new way of administering alteplase to remove clots from hemodialysis catheters. Currently, alteplase is left to dwell inside the catheter between dialysis treatments to dissolve the clot and restore blood flow through the catheter. We have developed a new way to administer alteplase by advancing it to the tip of the catheter at regular 10 minute intervals. We hypothesize that our new "push" protocol will dissolve clots in hemodialysis catheters better and faster than the current dwell method.

Timeline

Start
2004-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 2 mg Other

Indications